HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carcinogenicity study with epichlorohydrin (CEP) by gavage in rats.

Abstract
Weanling Wistar rats of both sexes were given epichlorohydrin by gastric intubation for 2 years, 5 times a week at dosages of 0, 2, and 10 mg/kg body weight. Mortality and body weight gain were recorded and histopathological examination for tumours was carried out; after 1 year also haematology was performed. Towards the end of the study a slight dose-related increase in mortality was observed in males, along with a decrease in mean body weight in the survivors. At pathological examination a high incidence (100% for females, 81% for males) of squamous cell carcinomas of low-grade malignancy was observed in the forestomach of animals at risk (greater than 18 months) from the 10 mg/kg group. In the 2 mg/kg group forestomach tumours were found at a lower incidence (7% for females, 14% for males), whereas this tumour was not found in control animals. Other tumours diagnosed in this study occurred at background level and were not influenced by treatment.
AuthorsP W Wester, C A Van der Heijden, A Bisschop, G J Van Esch
JournalToxicology (Toxicology) Vol. 36 Issue 4 Pg. 325-39 (Sep 1985) ISSN: 0300-483X [Print] Ireland
PMID4049437 (Publication Type: Journal Article)
Chemical References
  • Carcinogens
  • Chlorohydrins
  • Epichlorohydrin
Topics
  • Animals
  • Body Weight (drug effects)
  • Carcinogens
  • Carcinoma, Squamous Cell (chemically induced, pathology)
  • Chlorohydrins (toxicity)
  • Epichlorohydrin (toxicity)
  • Female
  • Hyperplasia (chemically induced)
  • Intubation, Gastrointestinal
  • Male
  • Papilloma (chemically induced, pathology)
  • Rats
  • Stomach (pathology)
  • Stomach Neoplasms (chemically induced, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: